Baxter launches FloSeal For surgical bleeding

Published: 2009-03-04 06:57:00

Updated: 2009-03-04 06:57:00

Baxter Internation Inc. said it has launched FlosSeal, an effective hemostat that stops bleeding in 2 minutes or less (median time to hemostasis).

The product will be supplied through NHS in Korea.

FloSeal is a proprietary combination of specially engineered collagen-derived particles and t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK